Literature DB >> 7376786

Effect of acute and repeated administration of gamma aminobutyric acid (GABA) on growth hormone and prolactin secretion in man.

F Cavagnini, C Invitti, M Pinto, C Maraschini, A Di Landro, A Dubini, A Marelli.   

Abstract

A single oral dose of 5 g gamma aminobutyric acid (GABA) was given to 19 subjects and serial venous blood samples were obtained before and 3 h after drug administration. A placebo was administered to 18 subjects who served as controls. GABA caused a significant elevation of plasma growth hormone levels (P less than 0.001), but did not consistently alter plasma prolactin concentration since only 5 out of 15 subjects showed an increase of the hormone. Eight additional subjects were submitted to an insulin tolerance test before and after per os administration of 18 g GABA daily for 4 days. Protracted GABA treatment significantly blunted the response of growth hormone and enhanced that of prolactin to insulin hypoglycaemia (P less than 0.01). These results indicate that pharmacological doses of GABA affect growth hormone and prolactin secretion in man. The precise nature of GABA's effects as well as its mechanism of action remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7376786     DOI: 10.1530/acta.0.0930149

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  17 in total

1.  Evidence for a GABAergic control of the exercise-induced rise in GH in man.

Authors:  L Steardo; M Iovino; P Monteleone; M Agrusta; F Orio
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 2.  Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.

Authors:  G Delitala; P Tomasi; R Virdis
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

Review 3.  Review article: health benefits of some physiologically active ingredients and their suitability as yoghurt fortifiers.

Authors:  A E Fayed
Journal:  J Food Sci Technol       Date:  2014-05-07       Impact factor: 2.701

4.  Effect of long-term treatment with sodium valproate on gonadotrophin and prolactin secretion in paediatric patients.

Authors:  A Masala; T Meloni; S Alagna; P P Rovasio; S Rassu; G Mele; V Franca
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

5.  Intravenous alprazolam challenge in normal subjects. Biochemical, cardiovascular, and behavioral effects.

Authors:  E D Risby; J K Hsiao; R N Golden; W Z Potter
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Dose-dependent effects of intravenous alprazolam on neuroendocrine, biochemical, cardiovascular, and behavioral parameters in humans.

Authors:  O T Osman; J K Hsiao; W Z Potter
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 7.  Benzodiazepines and anterior pituitary function.

Authors:  E Arvat; R Giordano; S Grottoli; E Ghigo
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

8.  Dose-related effects of gamma-amino beta-hydroxy butyric acid (GABOB) infusion on growth hormone secretion in normal women.

Authors:  G B Melis; A M Paoletti; V Mais; N M Mastrapasqua; F Strigini; F Fruzzetti; G Guarnieri; M Gambacciani; P Fioretti
Journal:  J Endocrinol Invest       Date:  1982 Mar-Apr       Impact factor: 4.256

Review 9.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

10.  Interference of dopamine infusion on gamma-amino butyric acid (GABA)-stimulated prolactin increase.

Authors:  G B Melis; A M Paoletti; V Mais; P Fioretti
Journal:  J Endocrinol Invest       Date:  1980 Oct-Dec       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.